Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125986802 | 12598680 | 2 | F | 201604 | 20160802 | 20160727 | 20160804 | EXP | US-JNJFOC-20160712803 | JOHNSON AND JOHNSON | 51.41 | YR | A | M | Y | 74.84000 | KG | 20160804 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125986802 | 12598680 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | N | UNKNOWN | 0 | 20 | MG | TABLET | QD | |||||
| 125986802 | 12598680 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | N | UNKNOWN | 0 | 20 | MG | TABLET | QD | |||||
| 125986802 | 12598680 | 3 | PS | XARELTO | RIVAROXABAN | 1 | Oral | N | UNKNOWN | 202439 | 20 | MG | TABLET | QD | |||||
| 125986802 | 12598680 | 4 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | N | 0 | UNSPECIFIED | |||||||||
| 125986802 | 12598680 | 5 | SS | ASPIRIN. | ASPIRIN | 1 | Unknown | U | 0 | 1500 | MG | UNSPECIFIED | |||||||
| 125986802 | 12598680 | 6 | SS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Unknown | U | U | 19872 | UNSPECIFIED | ||||||||
| 125986802 | 12598680 | 7 | SS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Unknown | U | U | 19872 | UNSPECIFIED | ||||||||
| 125986802 | 12598680 | 8 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 0 | 20 | MG | UNSPECIFIED | QD | |||||||
| 125986802 | 12598680 | 9 | C | LYRICA | PREGABALIN | 1 | Oral | 0 | 300 | MG | UNSPECIFIED | BID | |||||||
| 125986802 | 12598680 | 10 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125986802 | 12598680 | 1 | Deep vein thrombosis |
| 125986802 | 12598680 | 2 | Cardiac disorder |
| 125986802 | 12598680 | 3 | Cerebrovascular accident prophylaxis |
| 125986802 | 12598680 | 4 | Product used for unknown indication |
| 125986802 | 12598680 | 5 | Product used for unknown indication |
| 125986802 | 12598680 | 7 | Product used for unknown indication |
| 125986802 | 12598680 | 8 | Blood cholesterol abnormal |
| 125986802 | 12598680 | 9 | Nerve injury |
| 125986802 | 12598680 | 10 | Gastrooesophageal reflux disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125986802 | 12598680 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125986802 | 12598680 | Contusion | |
| 125986802 | 12598680 | Eczema | |
| 125986802 | 12598680 | Haemorrhage subcutaneous | |
| 125986802 | 12598680 | Inappropriate schedule of drug administration | |
| 125986802 | 12598680 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125986802 | 12598680 | 1 | 201604 | 0 | ||
| 125986802 | 12598680 | 2 | 201604 | 0 | ||
| 125986802 | 12598680 | 3 | 201604 | 0 | ||
| 125986802 | 12598680 | 8 | 2006 | 0 | ||
| 125986802 | 12598680 | 9 | 2006 | 0 | ||
| 125986802 | 12598680 | 10 | 2011 | 0 |